Eyes On Imprimis...

Shares of Imprimis Pharmaceuticals Inc. (IMMY) have returned more than 110% year-to-date while the iShares Nasdaq Biotechnology ETF (IBB) has fallen 4% during the same period.

from RTT - Biotech https://ift.tt/2yYuw4S
via IFTTT